4//SEC Filing
Schobel Alexander Mark 4
Accession 0001214659-21-001520
CIK 0001398733other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 8:17 PM ET
Size
6.4 KB
Accession
0001214659-21-001520
Insider Transaction Report
Form 4
Schobel Alexander Mark
Chief Innovation/Tech Officer
Transactions
- Sale
Common Stock
2021-02-10$6.75/sh−23,460$158,355→ 837,000 total - Sale
Common Stock
2021-02-09$6.75/sh−11,540$77,895→ 860,460 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 16, 2020.
Documents
Issuer
Aquestive Therapeutics, Inc.
CIK 0001398733
Entity typeother
Related Parties
1- filerCIK 0001406836
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 8:17 PM ET
- Size
- 6.4 KB